STOCK TITAN

AtriCure (ATRC) holder Hood River reports 6.23% stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Hood River Capital Management LLC filed Amendment No. 2 to a Schedule 13G reporting its beneficial ownership of AtriCure, Inc. common stock. The firm reports holding 3,096,611 shares, representing 6.23% of the outstanding common stock as of the event date.

Hood River discloses sole power to dispose of these 3,096,611 shares but no power to vote them. It certifies the position was acquired and is held in the ordinary course of business and not for the purpose of changing or influencing control of AtriCure.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Hood River Capital Management LLC
Signature:/s/ Robert Schmaltz
Name/Title:CCO, COO
Date:02/03/2026

FAQ

What stake in AtriCure (ATRC) does Hood River Capital report on this Schedule 13G/A?

Hood River Capital Management LLC reports beneficial ownership of 3,096,611 AtriCure common shares, representing 6.23% of the class. This stake reflects its economic interest in AtriCure stock as of the reported event date, without implying any change in corporate control intentions.

Does Hood River Capital have voting power over its AtriCure (ATRC) shares?

The filing states Hood River Capital has no sole or shared voting power over AtriCure shares. It reports zero shares with voting authority, while retaining sole dispositive power over 3,096,611 shares, meaning it can decide if and when to sell or otherwise dispose of them.

What type of SEC filing is this for AtriCure (ATRC) and what does Amendment No. 2 mean?

This is an Amendment No. 2 to a Schedule 13G, which updates a passive ownership report for AtriCure common stock. It revises prior disclosures to reflect Hood River Capital’s current beneficial ownership and related powers as of the stated event date, 12/31/2025.

How does Hood River Capital describe its investment purpose in AtriCure (ATRC) shares?

Hood River certifies the AtriCure securities were acquired and are held in the ordinary course of business. It states they were not acquired to change or influence control of AtriCure and are not part of any transaction intended to have that control-related purpose or effect.

Who signed the AtriCure (ATRC) Schedule 13G/A on behalf of Hood River Capital?

The Schedule 13G/A is signed by Robert Schmaltz, identified as CCO and COO. His signature certifies, after reasonable inquiry, that the information in the statement regarding Hood River Capital’s AtriCure holdings is true, complete, and correct as of the date signed.
Atricure

NASDAQ:ATRC

ATRC Rankings

ATRC Latest News

ATRC Latest SEC Filings

ATRC Stock Data

1.64B
47.99M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
MASON